Deans' stroke musings: Effect of soy on metabolic syndrome and cardiovascular risk factors: A randomized controlled trial

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, October 22, 2016

Effect of soy on metabolic syndrome and cardiovascular risk factors: A randomized controlled trial

Yet, this will NEVER be translated into a diet protocol publicly available to all. We have complete incompetency in our fucking failures of stroke associations. I've only referenced that failure 242 times. How can the employees, presidents and boards of directors live with themselves?
https://www.mdlinx.com/internal-medicine/medical-news-article/2016/10/19/soy-proteinlipidsmetabolic-syndrome-and-obesity/6910172/?news_id=387&newsdt=102216&subspec_id=4&utm_source=WeeklyNL&utm_medium=newsletter&utm_content=Weeks-Best-Article&

European Journal of Nutrition, 10/19/2016

Ruscica M, et al. – Researchers conducted this study to determine the impact of soy on metabolic syndrome and cardiovascular risk factors. It was observed in the findings that the inclusion of whole soy foods in a lipid–lowering diet significantly enhanced a relevant set of biomarkers connected with cardiovascular risk.

Methods

The study was composed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks.
To pursue this research whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount.

Results

Researchers found that soy nutritional intervention resulted in a lessening in the number of MetS features in 13/26 subjects.
In addition, in the soy group they observed a significant improvement of median percentage changes for body weight (-1.5 %) and BMI (-1.5 %), and additionally for atherogenic lipid markers, namely TC (-4.85 %), LDL-C (-5.25 %), non-HDL-C (-7.14 %) and apoB (-14.8 %).
Since the majority of the studied variables were strongly correlated, 3 factors were identified which explained the majority (52 %) of the total variance in the whole data set.
Among them, factor 1, which loaded lipid and adipose variables, clarified the 22 % of aggregate variance, demonstrating a statistically significant difference between treatment arms (p = 0.002).

Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report